About Proxima Therapeutics
Proxima Therapeutics is a Healthcare company based in Alpharetta (United States) founded in 1995, and was acquired by Cytyc in February 2005. Radiation delivery systems for malignant tumors are developed. Proxima Therapeutics has raised $31 million across 3 funding rounds from investors including Boston Scientific, Cytyc and Greenspring Associates. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its competitors include RefleXion, Mevion Medical Systems and ZAP-X; 3 of its 3 listed competitors have raised funding.
Company details
Proxima Therapeutics was founded in 1995 as a medical device company based in Alpharetta, United States. Site-specific radiation delivery systems for treating malignant tumors are developed and marketed, including GliaSite RTS for brain cancer and MammoSite RTS for breast cancer. Operations focus on oncology applications within the healthcare sector. As of February 2005, the company has been operated as a subsidiary of Cytyc Corporation.
- Headquarters Alpharetta, United States
- Stage Acquired
- SectorsHealthcare
- Website proximatherapeutics.com
- Social LinkedIn
- Acquired by Cytyc (Feb 2005)
- Total Equity Funding$31M (USD)
in 3 rounds
- Latest Funding Round$14M (USD), Series E
Aug 2002
- InvestorsBoston Scientific
& 7 more
- Acquired byCytyc
(Feb 2005)
Funding Insights of Proxima Therapeutics
Proxima Therapeutics has successfully raised a total of $31M across 3 strategic funding rounds. The most recent funding activity was a Series E round of $14 million completed in August 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31M
- Total Rounds 3
- Last Round Series E — $14M
- Investors Count 7
All 3 funding rounds of Proxima Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2002 | $14M | Series E | – | Greenspring Associates | |
| Feb 2001 | $17M | Series D | – | Domain Associates | |
| Jun 1998 | Unspecified | – | – |
8 investors in total: 8 institutional.
Investors in Proxima Therapeutics
Proxima Therapeutics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Cytyc and Greenspring Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified investment management firm | 2000 | greenspringassociates.com | Owings Mills, United States | |
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
Equity capital is provided to rapidly growing private companies. | lovettmiller.com | United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
| neuroventures.com | ||||
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States | |
Provides comprehensive financial services through venture partnerships and solutions. | 2000 | catvp.com | Bath, United Kingdom | |
Diagnostic medical devices for cancer and women's health are developed. | 1987 | cytyc.com | Marlborough, United States |
Investor details for Proxima Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Proxima Therapeutics
4 dated milestones of Proxima Therapeutics across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Proxima Therapeutics is founded.
- Funding First funding round.
- Funding Latest funding round, Series E, of $14.0M.
- Exit Acquired by Cytyc.
Competitors of Proxima Therapeutics
Proxima Therapeutics has 3 listed competitors in our database, 3 of them funded. They include RefleXion, Mevion Medical Systems and ZAP-X.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| reflexion.com | 2009 | Hayward, United States | $553.91M | 257 | Biology-guided radiotherapy systems are provided for cancer treatment. | |
| mevion.com | 2004 | Littleton, United States | $500.18M | 136 | Proton therapy systems are supplied for cancer radiation treatment. | |
| zapsurgical.com | 2014 | San Carlos, United States | $159M | Developer of gyroscopic radiosurgery platform |
Detailed competitors of Proxima Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Proxima Therapeutics (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Proxima Therapeutics
Complete news archive for Proxima Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proxima Therapeutics
Proxima Therapeutics was founded in 1995 and raised its 1st funding round 3 years after it was founded.
Proxima Therapeutics is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
Proxima Therapeutics is a funded company, having raised a total of $31M across 3 funding rounds to date.
Proxima Therapeutics was founded in 1995 as a medical device company based in Alpharetta, United States. Site-specific radiation delivery systems for treating malignant tumors are developed and marketed, including GliaSite RTS for brain cancer and MammoSite RTS for breast cancer. Operations focus on oncology applications within the healthcare sector. As of February 2005, the company has been operated as a subsidiary of Cytyc Corporation.
Proxima Therapeutics's top competitors include RefleXion, ZAP-X and Mevion Medical Systems.
Proxima Therapeutics has 8 investors. Key investors include Boston Scientific, Cytyc, Greenspring Associates, Domain Associates, and Lovett Miller & Co.
Yes. Proxima Therapeutics was acquired by Cytyc in February 2005.